Dr. Stuart Silverman, the Center’s founder and Medical Director, is a Clinical Professor of Medicine and Rheumatology at UCLA and a member of the National Osteoporosis Foundation (NOF) Scientific Advisory Board and Education Committee. He is board certified by the American Boards of Internal Medicine and Rheumatology and the co-joint Boards of Allergy and Immunology. He is internationally recognized in the fields of osteoporosis and fibromyalgia, and is a member of the National Advisory Boards of Amgen, Aventis, Eli Lilly & Company, Merck, Novartis, and Roche Laboratories.

Dr. Silverman has published over 40 peer review and scientific articles on rheumatology and osteoporosis as well as numerous abstracts and chapters. He is the developer of the Osteoporosis Assessment Questionnaire or OPAQ, an internationally used osteoporosis-targeted quality of life self-assessment instrument. His research interests in osteoporosis include quality of life measurement, prevention and treatment of postmenopausal and glucocorticoid osteoporosis, male osteoporosis, patient decision making, and development of patient education and self-management programs.

Dr. Silverman is a member of the International Osteoporosis Foundation’s committee of scientific advisors and a consultant to the NIH Osteoporosis and Related Bone Diseases-National Resource Center. He is also the Medical Director of the Fibromyalgia Rehabilitation Program of the Cedars-Sinai Medical Center as well as a member of the Advisory Board of the National Fibromyalgia Association. He maintains an active private practice and is the Principal Investigator for a number of multi-center research grants.